Topic 1

What general frameworks are used to assess risk/benefit in non-pharmaceutical industries or organizations?

(20 minute presentations)

8:45 am

Understanding the psychology of risk/benefit assessment

 

Discussion Leader: Jeffrey Leiden, M.D., Ph.D.

 

Paul Slovic, Ph.D.

President, Decision Research

 

Peter Ubel, M.D.

Director, Center for Behavioral and Decision Sciences in Medicine, University of Michigan

 

Sheila Jasanoff, J.D., Ph.D.

Professor, John F. Kennedy School of Government, Harvard University

9:45 am

Discussion

10:05 am

Break

10:20 am

Assessing the effectiveness of risk/benefit algorithms from other industries

 

Discussion Leader: Steven Galson, M.D., M.P.H.

 

Dennis Paustenbach, Ph.D.

President, ChemRisk

 

Jonathan M. Samet, M.D., M.S.

Professor and Chair, Department of Epidemiology, Johns Hopkins University

 

Joshua T. Cohen, Ph.D.

Lecturer, Tufts New England Medical Center

 

Richard Hall, Ph.D.

Vice President, Science and Technology (retired), McCormick & Company, Inc.

11:40 am

Discussion

12:00 pm

Lunch



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement